BIOMAT Database Logo BIOMAT Database Logo

Novel N-[1-(1-substituted 4-piperidinylmethyl)-4-piperidinyl]benzamides as potent colonic prokinetic agents. 2002

Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Medicinal Chemistry Group, Chemistry Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Enoki 33-94, Osaka 564-0053, Suita, Japan.

A series of novel N-[1-(1-substituted 4-piperidinylmethyl)-4-piperidinyl]benzamides was prepared and its compounds were evaluated for their binding to 5-HT(4) receptors and effects on gastrointestinal motility in conscious dogs. 4-Amino-N-[1-[1-(4-aminobutyl)-4-piperidinylmethyl]-4-piperidinyl]-5-chloro-2-methoxybenzamide (15) was found to have a potent binding affinity for 5-HT(4) receptors (IC(50): 6.47nM) and showed excellent colonic prokinetic activity.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004064 Digestive System A group of organs stretching from the MOUTH to the ANUS, serving to breakdown foods, assimilate nutrients, and eliminate waste. In humans, the digestive system includes the GASTROINTESTINAL TRACT and the accessory glands (LIVER; BILIARY TRACT; PANCREAS). Ailmentary System,Alimentary System
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005765 Gastrointestinal Agents Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. Digestants,Gastric Agents,Gastric Drugs,Gastrointestinal Drugs,Agents, Gastric,Agents, Gastrointestinal,Drugs, Gastric,Drugs, Gastrointestinal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001549 Benzamides BENZOIC ACID amides.
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017366 Serotonin Receptor Agonists Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. 5-HT Agonists,5-Hydroxytryptamine Agonists,Serotonin Agonists,5-HT Agonist,5-Hydroxytrytamine Agonist,Receptor Agonists, Serotonin,Serotonergic Agonist,Serotonergic Agonists,Serotonin Agonist,Serotonin Receptor Agonist,5 HT Agonist,5 HT Agonists,5 Hydroxytryptamine Agonists,5 Hydroxytrytamine Agonist,Agonist, 5-HT,Agonist, 5-Hydroxytrytamine,Agonist, Serotonergic,Agonist, Serotonin,Agonist, Serotonin Receptor,Agonists, 5-HT,Agonists, 5-Hydroxytryptamine,Agonists, Serotonergic,Agonists, Serotonin,Agonists, Serotonin Receptor,Receptor Agonist, Serotonin

Related Publications

Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
May 1990, Journal of medicinal chemistry,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
November 1978, Journal of medicinal chemistry,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents.
December 1985, Journal of medicinal chemistry,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin.
January 1976, Arzneimittel-Forschung,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Synthetic analgesics: N-(1-[2-arylethyl]-4-substituted 4-piperidinyl) N-arylalkanamides.
January 1976, Arzneimittel-Forschung,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Synthesis of N-[2-(1-piperidinyl)ethyl]benzamides.
January 2002, Chemical & pharmaceutical bulletin,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Hydroxylated N-alkyl-4-piperidinyl-2,3-diarylpyrrole derivatives as potent broad-spectrum anticoccidial agents.
October 2005, Bioorganic & medicinal chemistry letters,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Novel benzamides as selective and potent gastrokinetic agents. III. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-methoxy- and 2-ethoxy-N-[(4-substituted 2-morpholinyl)methyl]-benzamides.
March 1992, Chemical & pharmaceutical bulletin,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Novel benzamides as selective and potent gastrokinetic agents. IV. Synthesis and structure-activity relationships of 2-substituted 4-amino-N-[(4-benzyl-2-morpholinyl)methyl]-5-chlorobenzamides.
June 1992, Chemical & pharmaceutical bulletin,
Hiroshi Harada, and Hiroshi Yamazaki, and Yoshihito Toyotomi, and Hirotaka Tateishi, and Yukiko Mine, and Naoyuki Yoshida, and Shiro Kato
Novel 4-substituted 2-piperazinylquinazolines as potent anticonvulsive and antihypoxic agents.
May 1990, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!